Recent advancements in endocrinology have witnessed the integration of metabolomics and genomics, presenting a transformative paradigm for understanding the complexities of the endocrine system. This interdisciplinary approach holds the potential to redefine our comprehension of endocrine disorders, offering revolutionary diagnostic methods and precision therapies tailored to individual metabolic and genetic profiles. The growing knowledge of the underlying genetic causes of syndromes affecting endocrine organs underscores the crucial role of precision medicine in everyday clinical practice. The evolution of various omics sciences, including genomics, epigenomics, transcriptomics, metabolomics, and proteomics, is poised to transform the prevention, diagnosis, and treatment of endocrine conditions, presenting opportunities for targeted molecular therapies. In recent years, attempts to integrate rapidly growing different omics data through bioinformatics and molecular modeling have become invaluable, enhancing our understanding of cellular processes, and paving the way for novel therapeutic interventions.

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Metabolomics and Genomics in Endocrinology

  • Fatemeh Bandarian,
  • Hojat Dehghanbanadaki,
  • Patricia Khashayar,
  • Mostafa Rezaei-Tavirani,
  • Mahsa M.Amoli,
  • Nekoo Panahi,
  • Mahin Bandarian,
  • Farideh Razi

摘要

Recent advancements in endocrinology have witnessed the integration of metabolomics and genomics, presenting a transformative paradigm for understanding the complexities of the endocrine system. This interdisciplinary approach holds the potential to redefine our comprehension of endocrine disorders, offering revolutionary diagnostic methods and precision therapies tailored to individual metabolic and genetic profiles. The growing knowledge of the underlying genetic causes of syndromes affecting endocrine organs underscores the crucial role of precision medicine in everyday clinical practice. The evolution of various omics sciences, including genomics, epigenomics, transcriptomics, metabolomics, and proteomics, is poised to transform the prevention, diagnosis, and treatment of endocrine conditions, presenting opportunities for targeted molecular therapies. In recent years, attempts to integrate rapidly growing different omics data through bioinformatics and molecular modeling have become invaluable, enhancing our understanding of cellular processes, and paving the way for novel therapeutic interventions.